NEUROONE MEDICAL TECHNOLOGIES Corp

NMTC

Exchange: Nasdaq
Industry: Surgical & Medical Instruments & Apparatus
SEC CIK: 0001500198

SEC filings (opens in a new tab)

Insider trades, last 90 days

1 buy · 1 sell

Bought $67K
Sold $31.77K
Open-market purchases (P) and sales (S), counted by Form 4 filing.

View insider trades

13F holders, Q2 2026

26

−6 vs. Q1 2026
Total value $6.3M

View 13F holders

Superinvestors holding NMTC

0

None of the superinvestors held NMTC at the end of Q2 2026.

See all holders

Price chart

Chart by TradingView (opens in a new tab)

Latest insider trades

Open-market purchases and sales by NMTC insiders, newest first.

Insider trades
Filed (ET)	Trade date	Insider	Transaction	Shares	Avg price	Value	Shares after	Holding change	Filing
Sep 8, 20268:31 AM ET	Aug 27, 2026	Wambeke David J.Chief Business Officer	PPurchaseCommon Stock	+33.33K	$2.01	+$67K	200K	+20.0%	SEC
Jul 2, 20264:39 PM ET	Jun 30, 2026	Christianson MarkMarket Development Director	SSaleCommon Stock	−10K	$3.1773	−$31.77K	20.69K	−32.6%	SEC
Apr 1, 2026	Mar 30, 2026	Christianson MarkBusiness Development Director	SSaleCommon Stock	−15.36K	$0.74	−$11.37K	198.92K	−7.2%	SEC
Mar 16, 2026	Mar 12 – Mar 13, 2026	Christianson MarkBusiness Development Director	SSaleCommon Stock	−917	$0.80	−$733.6	214.28K	−0.4%	SEC
Mar 12, 2026	Mar 10 – Mar 11, 2026	Christianson MarkBusiness Development Director	SSaleCommon Stock	−13.72K	$0.80	−$10.98K	215.2K	−6.0%	SEC

Top 5 13F holders, Q2 2026

The largest institutional positions in NMTC at the end of Q2 2026.

Institutions holding NMTC in Q2 2026
Institution	Shares	Value	% of portfolio	Change in shares	Action
Bleichroeder LP	666,666	$2.03M	0.36%	−3,333,334−83.3%	Reduced
VANGUARD CAPITAL MANAGEMENT LLC	352,774	$1.07M	0.00%	−1,044,555−74.8%	Reduced
BARD ASSOCIATES INC	305,428	$928.5K	0.21%	−1,535,070−83.4%	Reduced
PERKINS CAPITAL MANAGEMENT INC	244,656	$743.75K	0.56%	−1,228,344−83.4%	Reduced
GEODE CAPITAL MANAGEMENT, LLC	93,555	$284.45K	0.00%	−522,051−84.8%	Reduced